ANGO vs BROS · rev $292.5M vs P/E 105, rev $1.28B
AngioDynamics Inc (ANGO) versus Dutch Bros Inc (BROS) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported BROS revenue for 2024-12-31 was $1.28B. Net income was $66.5M. Revenue was up 32.6% from 2023-12-31 to 2024-12-31. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
ANGO currently screens at market cap $378.5M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Not investment advice. Open the ANGO and BROS stock pages for the full models.
Not investment advice.